Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
33 hedge funds and large institutions have $27.4M invested in Anthera Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 32 → 33 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $35.7M → $27.4M (-$8.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
+$724K |
| 2 |
VAM
Visium Asset Management
New York
|
+$644K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$373K |
| 4 |
Franklin Resources
San Mateo,
California
|
+$371K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$317K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Bailard
Foster City,
California
|
-$708K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$291K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$142K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$129K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$128K |
ANTH Hedge Fund Activity: Q4 2013 in Review
33 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q4 2013, worth a combined $27.4M — down 23% from $35.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ANTH positions and 7 closed out — a net gain of 1 holder — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Moore Capital Management, opening a new position worth an estimated $724K. The largest seller was Bailard, exiting entirely with an estimated $708K sold.
- 33 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q4 2013, up from 32 in Q3 2013.
- Funds reported $27.4M of Anthera Pharmaceuticals, Inc. stock for Q4 2013, down 23% quarter-over-quarter.
- 8 funds opened new Anthera Pharmaceuticals, Inc. positions in Q4 2013 and 7 closed out, a net change of +1 holder.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q4 2013 was Moore Capital Management, an estimated $724K added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q4 2013 was Bailard, an estimated $708K sold.
Based on aggregated 13F filings for Q4 2013.